Eton Pharmaceutcials, Inc. Common Stock

ETONNASDAQ • USD
63.93 USD
↗ 2.48 (4.04%)AT CLOSE (03:59 PM EST)
63.25
↘ 0.68 (1.06%)
POST MARKET (AS OF 04:15 PM EST)
Post Market
AS OF 04:15 PM EST
63.25
↘ 0.68 (1.06%)
🔴Market: CLOSED

Eton Pharmaceutcials, Inc. Common Stock (ETON) trades at $63.93 per share. The stock presents a bullish profile across the board: both technical indicators and our fundamental models signal a "Strong Buy" and "Buy" respectively. Key drivers include a robust Altman Z-Score, exceptional Return on Equity (57.4%), a bullish Golden Cross on the moving averages and bullish moving average alignment. Furthermore, ETON is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Nov 13, 2026.

Open?$61.87
High?$65.18
Low?$61.01
Prev. Close?$61.45
Volume?601.3K
Avg. Volume?562.4K
VWAP?$63.38
Rel. Volume?1.07x
Bid / Ask
Bid?$62.00 × 3.0K
Ask?$64.50 × 400
Spread?$2.50
Midpoint?$63.25
Valuation & Ratios
Market Cap?1.8B
Shares Out?28.8M
Float?25.4M
Float %?88.9%
P/E Ratio?36.98
P/B Ratio?21.21
EPS?$1.73
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
Employees
44
Market Cap
1.8B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2018-11-14
Address
21925 W. FIELD PARKWAY
DEER PARK, IL 60010-7278
Phone: (847) 787-7361
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?
60
Z-Score?
100
Momentum?
92
Short Sent.?
60
Piotroski F-Score?5/9Mixed
Altman Z-Score?17.23Safe
Confidence?66%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?7.81%Elevated
Short Interest?2.0M
Days to Cover?5.4
Free Float25.4M
Avg Daily Volume365.6K
Settlement Date2026-10-30
Financial Health
Current Ratio?1.79Adequate
Quick Ratio?1.58Adequate
Cash Ratio?1.03Strong
Debt/Equity?0.27Low
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score
33/100
P/E?
Peers
100
S&P
19
37.0PRICEY▾
P/B?
Peers
100
S&P
6
21.21HIGH▾
P/S?
Peers
100
S&P
3
13.07HIGH▾
P/FCF?
Peers
100
S&P
11
48.3PRICEY▾
EV/EBITDA?
Peers
100
S&P
6
39.7HIGH▾
EV/Sales?
Peers
100
S&P
6
12.84HIGH▾
Returns & Efficiency
ROE?
Peers
50
S&P
92
57.4%STRONG▾
ROA?
Peers
50
S&P
97
31.7%STRONG▾
Cash Flow & Enterprise
FCF?$38.2M
Enterprise Value?$1.8B
Fundamentals ratios updated end of day